Skip to content

Analysis of Vital Signs in Patients With COVID-19

Analysis of Vital Signs in Patients With COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04927078
Enrollment
20
Registered
2021-06-15
Start date
2020-04-01
Completion date
2020-10-31
Last updated
2021-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Disease

Keywords

Breathing rate, Pulse rate, COVID 19, Patient monitoring

Brief summary

This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.

Detailed description

The investigators will analyse data from patients with known COVID 19 infection both during, and where possible before clinical COVID 19 infection and controls to determine whether changes can be detected in these parameters that precede overt clinical deterioration. The role of remote vision-based patient monitoring and management in supporting the care of patients with COVID-19 will be assessed through staff interviews.

Interventions

OTHERObservation of breathing pattern

Observations will be collected using a remote vision based patient monitoring and management system.

Sponsors

Royal Brompton & Harefield NHS Foundation Trust
CollaboratorOTHER
Oxehealth Limited
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients age 18 and above. Patients on wards with a medical diagnosis of COVID 19 who are in rooms with the Vision based patient monitoring and management system.

Exclusion criteria

Children will be excluded. No data will be excluded unless specifically requested by the treating clinician.

Design outcomes

Primary

MeasureTime frameDescription
Breathing ratesData will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19.Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.

Secondary

MeasureTime frameDescription
Pulse ratesData will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19.Pulse rate collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.
BR and PRData will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19.Similar data to be collected from control subjects

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026